A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.

Abstract Background It is unknown whether patients undergoing primary percutaneous coronary intervention (PCI) benefit from genotype-guided selection of oral P2Y12 inhibitors. Methods We conducted ...